Duchenne muscular dystrophy research program (dmdrp) support services for the congressionally directed medical research programs (cdmrp)
Ended Awarded Last action
- Contract number
- HT942525F0256
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $118,392
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 100% obligated
- $118,392.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $31,973 | |
| Original award | $86,419 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for $118,392.10 to provide support services for the Congressionally Directed Medical Research Programs' (CDMRP) Duchenne Muscular Dystrophy Research Program (DMDRP). The contract has a period of performance through May 14, 2026. Leidos, Inc. is a large, for-profit technology and engineering solutions provider that supports a variety of federal agencies through its Leidos Services Operating Segment. The contract is not set aside for any specific business category. Through this award, Leidos will provide administrative and technical support services for the DMDRP, which conducts research to advance treatments and improve the quality of life for individuals with Duchenne muscular dystrophy, a rare and debilitating genetic disorder.
Quick answers
Who was awarded contract HT942525F0256?
HT942525F0256 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on July 15, 2025.
How much is contract HT942525F0256 worth?
The government has obligated $118,392 on HT942525F0256.
Is contract HT942525F0256 an order under another contract?
Yes. HT942525F0256 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942525F0256 competed?
The extent of competition for HT942525F0256 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award